Extended-spectrum β-lactamase (ESBL)-producing Gram-negative pathogens are a major
cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the …

Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in
the 2000s as important human pathogens, have spread extensively throughout the world …

In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

Antimicrobial resistance is an urgent global health challenge in human and veterinary
medicine. Wild animals are not directly exposed to clinically relevant antibiotics; however …

Escherichia coli sequence type 131 (ST131) is an extensively antimicrobial-resistant E. coli
clonal group that has spread explosively throughout the world. Recent molecular …

The Escherichia coli sequence type (ST) 131 C2/H30Rx clade with the blaCTX-M-15 gene
had been most responsible for the global dissemination of extended-spectrum β-lactamase …

The abrupt expansion of Escherichia coli sequence type (ST) 131 is unmatched among
Gram negative bacteria. In many ways, ST131 can be considered a real-world model for the …

Escherichia coli strains belonging to diverse pathotypes have increasingly been recognized
as a major public health concern. The β-lactam antibiotics have been used successfully to …

Bacterial whole genome sequence (WGS) methods are rapidly overtaking classical
sequence analysis. Many bacterial sequencing projects focus on mobilome changes, since …

Escherichia coli ST131emerged during the early to mid-2000s is an important human
pathogen, has spread extensively throughout the world, and is responsible for the rapid …